Tirzepatide vs. Zepbound: Differences and Similarities

What is Tirzepatide?

What is Zepbound?

Tirzepatide vs. Zepbound: Are They the Same?

Trizepatide and Zepbound are more or less the same. The primary difference between the two lies solely in their branding and approved medical indications, rather than in their chemical composition or mechanism of action within the body.

Composition Comparison

Tirzepatide and Zepbound are compositionally identical. There are no differences in molecular structure, delivery method, or mechanism of action between the two.

Usage Distinctions

Zepbound is typically prescribed to adults with:

• A BMI of 30 or higher (classified as obesity)

• A BMI of 27 or higher with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol

Tirzepatide (as Mounjaro) is prescribed for managing type 2 diabetes. It may also promote weight loss, but that’s considered a secondary benefit in this context.

Brand vs. Generic Considerations

Is Generic Tirzepatide as Effective as Zepbound?

When a generic version of tirzepatide becomes available, patients can expect it to be just as effective as Zepbound.

• Efficacy Evaluation

Generic drugs must demonstrate “bioequivalence” to their branded counterparts: work the same way, in the same dosage, and with the same safety profile as the original.

• Safety Profiles

Common side effects, such as nausea, vomiting, and decreased appetite, would be the same for both versions, as they stem from the active ingredient, tirzepatide.

• Regulatory Approvals

Considerations When Choosing Between Tirzepatide and Zepbound

• Cost Implications

Zepbound, being a branded weight loss medication, can be more expensive, especially if not covered by insurance. For example, a monthly supply may cost over $1,000 CAD out-of-pocket. 

If a generic version of tirzepatide becomes available, that could dramatically reduce costs for weight loss users as well.

• Accessibility

Zepbound is FDA-approved in the U.S., but it has not yet been approved by Health Canada, which may delay access for Canadian patients. Tirzepatide (as Mounjaro) is available in Canada, but only for the treatment of diabetes. 

• Patient Suitability

To better understand how health profiles can determine the most suitable medication, see the example scenarios below.

1. Patient A, who has type 2 diabetes, may benefit more from a Mounjaro prescription, as it may be partially covered under her extended health plan.

2. Patient B, with a BMI over 30 but no diabetes, would likely be prescribed Zepbound if she were in the U.S., but may need to explore private telehealth options if in Canada.

3. Patient C, who has both obesity and hypertension, may qualify for Zepbound or Mounjaro, depending on his doctor’s approach.

Key Takeaways

• Tirzepatide is the active compound; Zepbound is a brand name for Tirzepatide. 

• Tirzepatide as Zepbound is FDA-approved for weight loss. Tirzepatide as Mounjaro is FDA-approved for type 2 diabetes. 

• Cost, coverage, and availability vary, so consult with your healthcare provider to determine the most accessible and affordable option for you.

Frequently Asked Questions

Is Zepbound approved for weight loss?
Yes. Zepbound was approved by the FDA in November 2023, specifically for chronic weight management in adults. It’s not currently approved by Health Canada, but that may change as regulatory reviews progress.

Can I switch from Zepbound to generic Tirzepatide?
You can, but only once a generic becomes available. Once available, your healthcare provider can help determine if switching is appropriate, taking into account cost, availability, and your treatment goals.

Is Zepbound stronger than semaglutide?
Yes, in many cases. Zepbound (tirzepatide) has demonstrated greater weight loss in clinical trials compared to semaglutide, which is used in Wegovy and Ozempic.